Alzheimer’s is Type 3 Diabetes

“The pharmaceutical industry has spent billions on amyloid-targeting therapies. Plaque-clearing drugs. Clinical trial after clinical trial. They keep failing. Because the plaques are not the cause. They are the symptom. The cause is metabolic dysfunction. Insulin resistance in the brain. You cannot drug your way out of a disease you are eating your way into.”

Scroll to Top